General Electric has submitted a confidential filing to spin out its healthcare business into a publicly traded company, with an IPO likely taking place early next year, according to a report from Bloomberg. An independent GE Healthcare would have a broad portfolio of its own—with work spanning cell therapy biomanufacturing, diagnostic imaging hardware, life sciences research, big data analytics and patient monitoring—as well as 52,000 employees and an enterprise value of up to $70 billion, according to previous Bloomberg estimates. Source: Fierce Biotech 19/12/2018.